Rakesh Jha - 18 Mar 2026 Form 3 Insider Report for ICICI BANK LTD (IBN)

Role
Director
Signature
/s/ Vivek Ranjan, as Attorney-in-fact
Issuer symbol
IBN
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 14:21:37 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jha Rakesh Director ICICI BANK TOWERS,, BANDRA-KURLA COMPLEX, MUMBAI, INDIA /s/ Vivek Ranjan, as Attorney-in-fact 18 Mar 2026 0002119536

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IBN Equity Shares, par value Rs. 2 per share 95,900 18 Mar 2026 Direct
holding IBN Equity Shares, par value Rs. 2 per share 176 18 Mar 2026 Held through Anand Vijay Jha, brother-in-law of Rakesh Jha
holding IBN Equity Shares, par value Rs. 2 per share 125 18 Mar 2026 Held through Navin Ahuja, sister's husband of Rakesh Jha
holding IBN Equity Shares, par value Rs. 2 per share 550 18 Mar 2026 Held through Narendra Kumar Jha, father of Rakesh Jha
holding IBN Equity Shares, par value Rs. 2 per share 6 18 Mar 2026 Held through Shilpi Jha, sister-in-law of Rakesh Jha

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 198,190 $14.67 Direct F1, F2, F3
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 196,000 $12.04 Direct F2, F3, F4
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 231,000 $9.67 Direct F2, F3, F5
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 249,100 $8.09 Direct F2, F3, F6
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 305,350 $6.16 Direct F2, F3, F7
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 449,500 $3.65 Direct F2, F3, F8
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 117,800 $4.35 Direct F2, F3, F9
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 365,750 $2.71 Direct F2, F3, F10
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 303,050 $2.40 Direct F2, F3, F11
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 478,500 $2.64 Direct F2, F3, F12
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 223,300 $3.03 Direct F2, F3, F13
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 127,600 $2.56 Direct F2, F3, F14
holding IBN Stock Option (Right to Buy) 18 Mar 2026 Equity Shares, par value Rs. 2 per share 70,125 $2.31 Direct F2, F3, F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A total of 198,190 stock options granted on April 17, 2025 and vesting in three tranches: (i) 59,457 vesting on April 17, 2026 and expiring on April 16, 2031, (ii) 59,457 vesting on April 17, 2027 and expiring on April 16, 2032, and (iii) 79,276 vesting on April 17, 2028 and expiring on April 16, 2033.
F2 Each stock option represents the contingent right to apply for one Equity Share.
F3 The exercise prices of the stock options are denominated in Rupee and translated for convenience only into USD at the rate of INR92.47 to US$1.00, the exchange rate set forth int he H.10 statistical release of the Federal Reserve Board on March 13, 2026.
F4 A total of 196,000 stock options granted on April 26, 2024 and vesting in three tranches: (i) 58,800 vested on April 26, 2025 and expiring on April 25, 2030, (ii) 58,800 vesting on April 26, 2026 and lapsing on April 25, 2031, and (iii) 78,400 vesting on April 26, 2027 and expiring on April 25, 2032.
F5 A total of 231,000 stock options granted on April 21, 2023 and vesting in three tranches: (i) 69,300 vested on April 21, 2024 and expiring on April 20, 2029, (ii) 69,300 vested on April 21, 2025 and expiring on April 20, 2030, and (iii) 92,400 vesting on April 21, 2026 and expiring on April 20, 2031.
F6 A total of 249,100 stock options granted on April 23, 2022 and vesting in three tranches: (i) 74,730 vested on April 23, 2023 and expiring on April 22, 2028, (ii) 74,730 vested on April 23, 2024 and expiring on April 22, 2029, and (iii) 99,640 vested on April 23, 2025 and expiring on April 22, 2030.
F7 A total of 305,350 stock options granted on April 24, 2021 and vesting in three tranches: (i) 91,605 vested on April 24, 2022 and expiring on April 23, 2027, (ii) 91,605 vested on April 24, 2023 and expiring on April 23, 2028, and (iii) 122,140 vested on April 24, 2024 and expiring on April 23, 2029.
F8 A total of 449,500 stock options granted on May 9, 2020 and vesting in three tranches: (i) 134,850 vested on May 9, 2021 and expiring on May 8, 2026, (ii) 134,850 vested on May 9, 2022 and expiring on May 8, 2027, and (iii) 179,800 vested on May 9, 2023 and expiring on May 8, 2028.
F9 A total of 294,500 stock options granted on May 6, 2019 and vesting in three tranches: (i) 88,350 vested on May 6, 2020 and expired on May 5, 2025, which have been fully exercised by the Reporting Person prior to expiration, (ii) 88,350 vested on May 6, 2021 and expiring on May 5, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iii) 117,800 vested on May 6, 2022 and expiring on May 5, 2027.
F10 A total of 365,750 stock options granted on May 3, 2017 and vesting in three tranches: (i) 109,725 vested on May 3, 2018 and expiring on May 2, 2028, (ii) 109,725 vested on May 3, 2019 and expiring on May 2, 2029, and (iii) 146,300 vested on May 3, 2020 and expiring on May 2, 2030.
F11 A total of 303,050 stock options granted on April 28, 2016 and vesting in three tranches: (i) 90,915 vested on April 28, 2017 and expiring on April 27, 2027, (ii) 90,915 vested on April 28, 2018 and expiring on April 27, 2028, and (iii) 121,220 vested on April 28, 2019 and expiring on April 27, 2029.
F12 A total of 478,500 stock options granted on September 16, 2015 and vesting in two tranches: (i) 239,250 vested on April 30, 2018 and expiring on April 29, 2028 and (ii) 239,250 vested on April 30, 2019 and expiring on April 29, 2029.
F13 A total of 319,000 stock options granted on April 27, 2015 and vesting in three tranches: (i) 95,700 vested on April 27, 2016 and expiring on April 26, 2026, which have been fully exercised by the Reporting Person prior to expiration, (ii) 95,700 vested on April 27, 2017 and expiring on April 26, 2027, and (iii) 127,600 vested on April 27, 2018 and expiring on April 26, 2028.
F14 A total of 319,000 stock options granted on April 25, 2014 and vesting in three tranches: (i) 95,700 vested on April 25, 2015 and expired on April 24, 2025, which have been fully exercised by the Reporting Person prior to expiration, (ii) 95,700 vested on April 25, 2016 and expiring on April 24, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iii) 127,600 vested on April 25, 2017 and expiring on April 24, 2027.
F15 A total of 233,750 stock options granted on April 26, 2013 and vesting in four tranches: (i) 46,750 vested on April 26, 2014 and expiring on April 25, 2024, which have been fully exercised by the Reporting Person prior to expiration, (ii) 46,750 vested on April 26, 2015 and expiring on April 25, 2025, which have been fully exercised by the Reporting Person prior to expiration, (iii) 70,125 vested on April 26, 2016 and expiring on April 25, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iv) 70,125 vested on April 26, 2017 and expiring on April 25, 2027.

Remarks:

Exhibit 24.1. See power of attorney attached